ADVERTISEMENT

Fine, jail for failing to report TB cases

March 21, 2018 10:02 pm | Updated March 22, 2018 02:10 pm IST - NEW DELHI

Move to improve notification from private hospitals

A file photo of a patient undergoing treatment for TB in Varanasi.

Chemists and hospital staff treating tuberculosis (TB) patients, who don’t inform health authorities about them, could face up to two years in jail, says a notification by the Union Health Ministry. The notification, made public on March 16, requires chemists and druggists to provide district officials with personal details and information on the medicines taken by TB patients.

India has the maximum number of TB patients and many of them seek treatment in private hospitals. The notification, according to authorities, seeks to push private hospitals and establishments to do more for containing the spread of TB.

A 2014 study in

ADVERTISEMENT

The Lancet reported that there were 2.2 million TB patients treated in India’s private sector alone, or about 2-3 times higher than current estimates of the incidence of the disease. This could be an underestimated number as the analysis did not account for cases of drug-resistant tuberculosis.

ADVERTISEMENT

According to a WHO report released in January , India had about 2.79 million new cases of TB in 2016 and the disease killed about 4,35,000 persons. Only about 1.3 million of them were known to be receiving treatment under the government’s TB control programme, and only about 3,30,000of these patients emerged from the private sector. “The aim is primarily to improve notification [of TB patients] from the private sector,” said Sunil Kharpade, an official involved in India’s TB control programme.

This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
This is your last free article.

ADVERTISEMENT

ADVERTISEMENT